B cell activating factor in obesity is regulated by oxidative stress in adipocytes

Journal of Clinical Biochemistry and Nutrition

Volumn 52, Issue 2, 2013, Pages 120-127

  Tada, Fujimasa ^a   Abe, Masanori ^a   Kawasaki, Keitarou ^a   Miyake, Teruki ^a   Shiyi, Chen ^a   Hiasa, Yoichi ^a   Matsuura, Bunzo ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipocytes; B cell activation factor; Nuclear factor B; Obesity; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; B CELL ACTIVATING FACTOR; HYDROGEN PEROXIDE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

MUS;

EID: 84875904938     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.12-115     Document Type: Article

References (39)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105. (Pubitemid 29466221)
3. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79. (Pubitemid 36026281)
4. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2001; 335: 1134.
5. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578. (Pubitemid 351232031)
6. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867. (Pubitemid 46024993)
7. Shoelson SE, Lee J, Goldfme AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801. (Pubitemid 44033299)
8. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97.
9. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783. (Pubitemid 44453463)
10. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-949. (Pubitemid 40712793)
11. Hosogai N, Fukuhara A, Oshima K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901-911. (Pubitemid 46525054)
12. Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999; 189: 1747-1756. (Pubitemid 29272691)
13. Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999; 285: 260-263. (Pubitemid 29330000)
14. Nardelli B, Belvedere 0, Roschke V, et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001; 97: 198-204. (Pubitemid 32061261)
15. Ittah M, Miceli-Richard C, Eric Gottenberg J, et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Res Ther 2006; 8: R51.
16. Pelekanou V, Kampa M, Kafousi M, et al. Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas. BAFF Cancer 2008; 8: 76.
17. Kim YH, Choi BH, Cheon HG, Do MS. B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation. Exp Mol Med 2009; 41 : 208-216.
18. Alexaki VI, Notas G, Pelekanou V, et al. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fnl4, BAFF-R, TACl, and BCMA) at different stages of normal and pathological adipose tissue development.J Immunol 2009; 183: 5948-5956.
19. Hamada M, Abe M, Miyake T, et al. B cell-activating factor controls the production of adipokines and induces insulin resistance. Obesity (Silver Spring) 2011; 19: 1915-1922.
20. Miyake T, Abe M, Tokumoto Y, et al. B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease. Hepatol Int 2012. DOI: 10.1007/s12072-012-9345-8
21. Miyake T, Akbar SM, Yoshida O, et al. Impaired dendritic cell fimctions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver dhtsise. J Gastroenterol 2010; 45: 859-867.
22. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondi-aldehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15: 316-328. (Pubitemid 41190990)
23. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. C/in Invest 2004; 114: 1752-1761. (Pubitemid 40385531)
24. Fu L, Lin-Lee YC, Pham LV, Tamayo A, Yoshimura L, Ford RJ. Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 2006; 107:4540-4548. (Pubitemid 43801383)
25. Tai YT, Li XF, Breitkreutz I, et al. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. Cancer Res 2006; 66: 6675-6682. (Pubitemid 44085624)
26. Moon EY, Lee JH, Oh SY, et al. Reactive oxygen species augment B-cell-activating factor expression. Free Radic Biol Med 2006; 40: 2103-2111.
27. Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996; 97: 2152-2157.
28. Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia, J Exp Med 1997; 185: 171-175. (Pubitemid 27039451)
29. Suganami T, Tanimoto-Koyama K, Nishida J, et al. Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vase Biol 2007; 27: 84-91. (Pubitemid 46370478)
30. Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vase Biol 2003; 23: 434-439. (Pubitemid 36337219)
31. Sankhia M, Sharma TK, Mathur K, et al. Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome. Clin Lab 2012;58:385-392.
32. Lin CC, Yin MC. Effects of cysteine-containing compounds on biosynthesis of triacylglycerol and cholesterol and anti-oxidative protection in liver from mice consuming a high-fat diet. Br J Nutr 2008; 99: 37-43.
33. Wang T, Si Y, Shirihai OS, et al. Respiration in adipocytes is inhibited by reactive oxygen species. Obesity (Silver Spring) 2010; 18: 1493-1502.
34. Elshorbagy AK, Valdivia-Garcia M, Mattocks DA, et al. Effect of taurine and N-acetylcysteine on methionine restriction-mediated adiposity resistance. Metabolism 2012. DOI:10.1016/j.metabol.2012.10.005
35. Diniz YS, Rocha KK, Souza GA, et al. Effects of Af-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats. Eur J Pharmacol 2006; 543: 151-157. (Pubitemid 44092691)
36. El Midaoui A, Ismael MA, Lu H, Fantus IG, de Champlain J, Couture R. Comparative effects of 4-aeetyl-L-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats. Can J Physiol Pharmacol 2008; 86: 752-760.
37. Oliveira-Marques V, Marinho HS, Cyme L, Antunes F. Role of hydrogen peroxide in >JF-kB activation: from inducer to modulator. Antioxid Redox Signal 2009; 11:2223-2243.
38. Flohe L, Brigelius-Flohi R, Saliou C, Traber MG, Packer L. Redox regulation of NF-κB activation. Free Radic Biol Med 1991; 22: 1115-1126.
39. Berg AH, Lin Y, Lisanti MP, Scherer PE. Adipocyte differentiation induces dynamic changes in NF-κB expression and activity. Am J Physiol Endocrinol Metab 2004; 287: El 178-El 188.